Pasar al contenido principal

SUPERFICIES OPTICAS MULTIFUNCIONALES PARA PANTALLAS DE VISUALIZACION

TEC2016-75080-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE CIENCIAS FOTONICAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Early sepsis diagnosis via protein and miRNA biomarkers using a novel point-of-care photonic biosensor

  • Fabri-Faja, Nuria
  • Calvo-Lozano, Olalla
  • Dey, Priyanka
  • Terborg, Roland A.
  • Estévez, M. Carmen
  • Belushkin, Alexander
  • Yesilköy, Filiz
  • Duempelmann, Luc
  • Altug, Hatice
  • Pruneri, Valerio
  • Lechuga, Laura M.
Sepsis is a condition characterized by a severe stage of blood-infection often leading to tissue damage, organ failure and finally death. Fast diagnosis and identification of the sepsis stage (sepsis, severe sepsis or septic shock) is critical for the patient's evolution and could help in defining the most adequate treatment in order to reduce its mortality. The combined detection of several biomarkers in a timely, specific and simultaneous way could ensure a more accurate diagnosis. We have designed a new optical point-of-care (POC) device based on a phase-sensitive interferometric biosensor with a label-free microarray configuration for potential high-throughput evaluation of specific sepsis biomarkers. The sensor chip, which relies on the use of metallic nanostructures, provides versatility in terms of biofunctionalization, allowing the efficient immobilization of different kind of receptors such as antibodies or oligonucleotides. We have focused on two structurally different types of biomarkers: proteins, including C-reactive protein (CRP) and Interleukin 6 (IL6), and miRNAs, using miRNA-16 as an example. Limits of Detection (LoD) of 18 μg mL−1, 88 μg mL−1 and 1 μM (6 μg mL−1) have been respectively obtained for CRP, IL6 and miRNA-16 in individual assays, with high accuracy and reproducibility. The multiplexing capabilities have also been assessed with the simultaneous analysis of both protein biomarkers., We thank the financial support from the European Union’s Horizon 2020 Research and Innovation program (RAIS Project, grant agreement 644956). The ICN2 is funded by the CERCA program / Generalitat de Catalunya. ICN2 is supported by the Severo Ochoa program from Spanish MINECO (Grant No. SEV-2017-0706). ICN2 thanks FEDER funds from the European Regional Development Funds program (Project FICTS-1420-27 selected by MINECO). LD acknowledges financial support funded by the SNSF through an Early Postdoc Mobility Fellowship (No. 178438). RT, LD, and VP acknowledge financial support from the Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R&D (SEV-2015-0522) and OPTO-SCREEN (TEC2016-75080-R), from Fundació Privada Cellex, from Generalitat de Catalunya through the CERCA program and AGAUR 2017 SGR 1634., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Label-free bacteria quantification in blood plasma by a bioprinted microarray based interferometric point-of-care device

  • Dey, Priyanka
  • Fabri-Faja, Nuria
  • Calvo-Lozano, Olalla
  • Terborg, Roland A.
  • Belushkin, Alexander
  • Yesilköy, Filiz
  • Fàbrega, Anna
  • Ruiz-Rodriguez, Juan Carlos
  • Ferrer, Ricard
  • González-López, Juan José
  • Estévez, M. Carmen
  • Altug, Hatice
  • Pruneri, Valerio
  • Lechuga, Laura M.
Existing clinical methods for bacteria detection lack speed, sensitivity, and, importantly, point-of-care (PoC) applicability. Thus, finding ways to push the sensitivity of clinical PoC biosensing technologies is crucial. Here we report a portable PoC device based on lens-free interferometric microscopy (LIM). The device employs high performance nanoplasmonics and custom bioprinted microarrays and is capable of direct label-free bacteria ( E. coli) quantification. With only one-step sample handling we offer a sample-to-data turnaround time of 40 min. Our technology features detection sensitivity of a single bacterial cell both in buffer and in diluted blood plasma and is intrinsically limited by the number of cells present in the detection volume. When employed in a hospital setting, the device has enabled accurate categorization of sepsis patients (infectious SIRS) from control groups (healthy individuals and noninfectious SIRS patients) without false positives/negatives. User-friendly on-site bacterial clinical diagnosis can thus become a reality., We acknowledge the financial support from European Union’s Horizon 2020 Research and Innovation program (RAIS Project, grant agreement 644956). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa programme of the Spanish Ministry of Economy, Industry and Competitiveness (MINECO, grant no. SEV-2013-0295). ICN2 thanks FEDER funds from the European Regional Development Funds program (Project FICTS-1420-27 selected by MINECO). R.T. and V.P. acknowledge financial support from the Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R&D (SEV-2015-0522) and OPTO-SCREEN (TEC2016-75080-R), from Fundacio Privada Cellex, from Generalitat de Catalunya through the CERCA program and AGAUR 2017 SGR 1634. R.T. acknowledges support from the International PhD fellowship program ’la Caixa’ Severo Ochoa at ICFO. The VHIR-HUVH is supported by Plan Nacional de I+D+i 2013−2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003) - cofinanced by European Development Regional Fund “A way to achieve Europe”, Operative program Intelligent Growth 2014., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early sepsis diagnosis via protein and miRNA biomarkers using a novel point-of-care photonic biosensor

  • Fabri Faja, Nuria|||0000-0002-6778-8467
  • Calvo Lozano, Olalla|||0000-0001-5486-2237
  • Dey, Priyanka|||0000-0002-7158-4491
  • Terborg, Roland A.
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Belushkin, Alexander|||0000-0003-1928-2223
  • Yesilköy, Filiz|||0000-0001-8483-3285
  • Duempelmann, Luc
  • Altug, Hatice|||0000-0001-5522-1343
  • Pruneri, Valerio
  • Lechuga, Laura M.|||0000-0001-5187-5358
Sepsis is a condition characterized by a severe stage of blood-infection often leading to tissue damage, organ failure and finally death. Fast diagnosis and identification of the sepsis stage (sepsis, severe sepsis or septic shock) is critical for the patient's evolution and could help in defining the most adequate treatment in order to reduce its mortality. The combined detection of several biomarkers in a timely, specific and simultaneous way could ensure a more accurate diagnosis. We have designed a new optical point-of-care (POC) device based on a phase-sensitive interferometric biosensor with a label-free microarray configuration for potential high-throughput evaluation of specific sepsis biomarkers. The sensor chip, which relies on the use of metallic nanostructures, provides versatility in terms of biofunctionalization, allowing the efficient immobilization of different kind of receptors such as antibodies or oligonucleotides. We have focused on two structurally different types of biomarkers: proteins, including C-reactive protein (CRP) and Interleukin 6 (IL6), and miRNAs, using miRNA-16 as an example. Limits of Detection (LoD) of 18 μg mL, 88 μg mL and 1 μM (6 μg mL) have been respectively obtained for CRP, IL6 and miRNA-16 in individual assays, with high accuracy and reproducibility. The multiplexing capabilities have also been assessed with the simultaneous analysis of both protein biomarkers.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Label-free Bacteria Quantification in Blood Plasma by a Bioprinted Microarray Based Interferometric Point-of-Care Device

  • Dey, Priyanka|||0000-0002-7158-4491
  • Fabri Faja, Nuria|||0000-0002-6778-8467
  • Calvo Lozano, Olalla|||0000-0001-5486-2237
  • Terborg, Roland A.
  • Belushkin, Alexander|||0000-0003-1928-2223
  • Yesilköy, Filiz|||0000-0001-8483-3285
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • Ruiz Rodríguez, Juan Carlos
  • Ferrer, Ricard|||0000-0002-4859-4747
  • González-López, Juanjo|||0000-0003-2419-5909
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Altug, Hatice|||0000-0001-5522-1343
  • Pruneri, Valerio
  • Lechuga, Laura M.|||0000-0001-5187-5358
Existing clinical methods for bacteria detection lack speed, sensitivity, and, importantly, point-of-care (PoC) applicability. Thus, finding ways to push the sensitivity of clinical PoC biosensing technologies is crucial. Here we report a portable PoC device based on lens-free interferometric microscopy (LIM). The device employs high performance nanoplasmonics and custom bioprinted microarrays and is capable of direct label-free bacteria (E. coli) quantification. With only one-step sample handling we offer a sample-to-data turnaround time of 40 min. Our technology features detection sensitivity of a single bacterial cell both in buffer and in diluted blood plasma and is intrinsically limited by the number of cells present in the detection volume. When employed in a hospital setting, the device has enabled accurate categorization of sepsis patients (infectious SIRS) from control groups (healthy individuals and noninfectious SIRS patients) without false positives/negatives. User-friendly on-site bacterial clinical diagnosis can thus become a reality.